What does Biolynx do?

Biolynx is a research organisation in Gent. Private Limited, started on 24 April 2015, 1 establishment.

What is the address of Biolynx?

The registered office of Biolynx is located at Boomstraat 62A, 9000 Gent.

Is Biolynx still active?

Yes. According to the CBE (2 November 2026) Biolynx is active, legal situation “Normale toestand”, started on 24 April 2015.

Is Biolynx registered on Peppol?

Yes, Biolynx is registered on the Peppol network with ID 0208:0628875744.

What is the enterprise number of Biolynx?

The enterprise number of Biolynx is BE0628875744.

When was Biolynx founded?

Biolynx was founded on 24 April 2015.

Who are the directors of Biolynx?

According to the 2025 annual accounts, the directors of Biolynx are: Bart Kregersman.

Is Biolynx a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 April 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Biolynx make in 2025?

Biolynx posted a profit after taxes of € 100,835 in financial year 2025.

What is the revenue of Biolynx?

As a small company, Biolynx is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 432,911.

Biolynx (Private Limited) - Gent - BE0628875744

Dossier Biolynx, printed on 2 November 2026 from databakkes.be/en/0628875744/biolynx. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Biolynx from Gent, company number BE0628875744, closed financial year 2025 with a result of € 100,835 after tax. For that financial year Biolynx recorded a gross margin of € 432,911 and equity of € 586,138. Compared with financial year 2024, the result moved from € 254,302 to € 100,835. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 11, 2026.

What it is worth Healthy

€ 586,138

▼ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 100,835

▼ 60% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 194,032

▲ 146% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 247,071 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 267,897

▲ 25% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 59,395

▲ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 12,031

▼ 64% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 88,070

▲ 44% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 310,497 Gross margin 2022: € 310,497 First fiscal year in the series	€ 488,965 Gross margin 2023: € 488,965 ▲ 57% vs 2022 (€ 310,497) Favourable step	€ 579,880 Gross margin 2024: € 579,880 ▲ 19% vs 2023 (€ 488,965) Favourable step	€ 432,911 Gross margin 2025: € 432,911 ▼ 25% vs 2024 (€ 579,880) Unfavourable step	▼ 25%
Profit after taxes	€ 128,948 Profit after taxes 2022: € 128,948 First fiscal year in the series	€ 188,500 Profit after taxes 2023: € 188,500 ▲ 46% vs 2022 (€ 128,948) Favourable step	€ 254,302 Profit after taxes 2024: € 254,302 ▲ 35% vs 2023 (€ 188,500) Favourable step	€ 100,835 Profit after taxes 2025: € 100,835 ▼ 60% vs 2024 (€ 254,302) Unfavourable step	▼ 60%
Equity	€ 324,476 Equity 2022: € 324,476 First fiscal year in the series	€ 498,324 Equity 2023: € 498,324 ▲ 54% vs 2022 (€ 324,476) Favourable step	€ 740,249 Equity 2024: € 740,249 ▲ 49% vs 2023 (€ 498,324) Favourable step	€ 586,138 Equity 2025: € 586,138 ▼ 21% vs 2024 (€ 740,249) Unfavourable step	▼ 21%
Total debts	€ 495,695 Total debts 2022: € 495,695 First fiscal year in the series	€ 315,390 Total debts 2023: € 315,390 ▼ 36% vs 2022 (€ 495,695) Favourable step	€ 647,973 Total debts 2024: € 647,973 ▲ 105% vs 2023 (€ 315,390) Unfavourable step	€ 903,728 Total debts 2025: € 903,728 ▲ 39% vs 2024 (€ 647,973) Unfavourable step	▲ 39%
Cash	€ 246,971 Cash 2022: € 246,971 First fiscal year in the series	€ 173,507 Cash 2023: € 173,507 ▼ 30% vs 2022 (€ 246,971) Unfavourable step	€ 78,951 Cash 2024: € 78,951 ▼ 54% vs 2023 (€ 173,507) Unfavourable step	€ 194,032 Cash 2025: € 194,032 ▲ 146% vs 2024 (€ 78,951) Favourable step	▲ 146%
Retained profit	€ 305,876 Retained profit 2022: € 305,876 First fiscal year in the series	€ 479,724 Retained profit 2023: € 479,724 ▲ 57% vs 2022 (€ 305,876) Favourable step	€ 721,649 Retained profit 2024: € 721,649 ▲ 50% vs 2023 (€ 479,724) Favourable step	€ 567,538 Retained profit 2025: € 567,538 ▼ 21% vs 2024 (€ 721,649) Unfavourable step	▼ 21%
Dividend	€ 105,687 Dividend 2022: € 105,687 First fiscal year in the series	€ 4,861 Dividend 2023: € 4,861 ▼ 95% vs 2022 (€ 105,687) Unchanged	€ 1,011 Dividend 2024: € 1,011 ▼ 79% vs 2023 (€ 4,861) Unchanged	€ 247,071 Dividend 2025: € 247,071 ▲ € 246,060 vs 2024 (€ 1,011) Unchanged	▲ € 246,060
Balance sheet total	€ 820,171 Balance sheet total 2022: € 820,171 First fiscal year in the series	€ 813,713 Balance sheet total 2023: € 813,713 ▼ 1% vs 2022 (€ 820,171) Unchanged	€ 1,388,222 Balance sheet total 2024: € 1,388,222 ▲ 71% vs 2023 (€ 813,713) Unchanged	€ 1,489,867 Balance sheet total 2025: € 1,489,867 ▲ 7% vs 2024 (€ 1,388,222) Unchanged	▲ 7%

Key figures of Biolynx, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Biolynx?

What happened at Biolynx in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 11, 2026 New annual accounts for financial year 2025: profit of € 100,835 (▼ 60% vs 2024). Source: NBB ↗
Jul 1, 2015 New establishment in Gent. KBO
Apr 24, 2015 Start of the company according to the CBE. KBO

In short

From € 128,948 profit in 2022 to € 100,835 profit in 2025.

Paid € 130,205 in corporate taxes since 2022.

Best year ever: 2024, with € 254,302 profit.

Paid out € 358,629 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Bart Kregersman

Biolynx

Behind Biolynx is Bart Kregersman.

Directors

According to the 2025 annual accounts

Bart Kregersman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Boomstraat 62A

9000 Gent

2.242.888.735

Boomstraat 62 box A

9000 Gent

Active since 1 July 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0628.875.744

VAT number

BE 0628.875.744

Registered office

Boomstraat 62A, 9000 Gent

Names & denominations

Biolynx

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 April 2015

Peppol

Active · Active since 12 Jan 2026

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige technische testen en toetsen

View on CBE Public ↗ Annual accounts (NBB) ↗

Biolynx

Financials

What happened to Biolynx?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions